The CAPS Screen: 10 Fit Health-Care Stocks

In 2006, the United States spent about $2.1 trillion on health care. With an aging population that's increasing in number, and escalating costs of medical care and technology, that figure is expected to grow 6.7% annually to reach $4.3 trillion in 2017.

With that in mind, I used our new CAPS screening tool to find out which health-care stocks the CAPS investing community is the most bullish on.

These stocks also have:

• Market caps greater than $1 billion.
• Five-star ratings, the highest possible, from our CAPS community.

Remember, in the first year for which we have data, five-star companies outperformed with an average gain of nearly 28%.

Company	Share Price	Market Cap (in billions)
Amedisys	$52.41	$1.4
China Medical (Nasdaq: CMED  )	$39.30	$1.1
Genzyme (Nasdaq: GENZ  )	$68.43	$18.3
Gilead Sciences (Nasdaq: GILD  )	$53.87	$49.7
Hologic (Nasdaq: HOLX  )	$22.09	$5.6
Johnson & Johnson	$66.15	$186.4
Meridian Bioscience	$29.28	$1.2
Mindray Medical (NYSE: MR  )	$37.63	$4.0
Stryker (NYSE: SYK  )	$62.30	$25.7
Teva Pharmaceutical (Nasdaq: TEVA  )	$45.93	$35.6

Data from Motley Fool CAPS and Yahoo! Finance as of May 20.

Of course, true Fools know that it takes more than a screen to generate healthy returns. Come and join us on Motley Fool CAPS, where the collective wisdom of our 105,000-strong CAPS community can help you make your investment decisions.

If you’re looking for more investment ideas, try our Rule Breakers growth-stock newsletter. You can read all our past recommendations, including our favorite opportunities in health care and medicine, free for 30 days, with no obligation.

For more Foolish content:

• Early Signs of Winning Stocks
• The CAPS Screen: 10 Mouth-Watering Consumer Stocks
• The One Stock You Must Buy